Wave Life Sciences (WVE) Change in Accured Expenses (2014 - 2026)

Wave Life Sciences' Change in Accured Expenses history runs 13 years deep, the most recent figure standing at -$13.5 million for Q1 2026.

• Quarterly Change in Accured Expenses fell 1.91% year-over-year to -$13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (up 338.76% YoY) and the FY2025 annual result came in at $5.5 million, up 28.92% from the prior year.
• Change in Accured Expenses was -$13.5 million for Q1 2026 at Wave Life Sciences, down from $10.1 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $10.1 million in Q4 2025 and bottomed at -$13.5 million in Q1 2026.
• A 5-year average of -$106941.2 and a median of $3.5 million in 2025 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses plunged 102.01% — and 2023, when it jumped 7668.97%.
• Wave Life Sciences' Change in Accured Expenses stood at $6.5 million in 2022, then sank by 35.28% to $4.2 million in 2023, then soared by 65.06% to $6.9 million in 2024, then jumped by 45.22% to $10.1 million in 2025, then sank by 234.18% to -$13.5 million in 2026.
• Business Quant data shows WVE's Change in Accured Expenses at -$13.5 million in Q1 2026, $10.1 million in Q4 2025, and $3.5 million in Q3 2025.